Balance Training in Parkinson's Disease Using the Wii Balance Board

This study has been completed.
Sponsor:
Information provided by:
Rehabilitation Institute of Chicago
ClinicalTrials.gov Identifier:
NCT01228851
First received: August 31, 2010
Last updated: July 26, 2011
Last verified: July 2011
  Purpose

The purpose of this study is to assess the facilitation of balance in Parkinson's disease (PD) patients using the Nintendo Wii fit, with the ultimate goal of developing a program for function and fitness in this patient population. In this study, PD patients will participate in group exercise classes using the Wii Fit and the effects on balance, postural sway, and quality of life assessed.


Condition Intervention
Parkinson's Disease
Other: Balance Training

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Pilot Study of the Effects of Balance Training Using the Wii Balance Board on Balance and Ambulation in Adults With Parkinson's Disease

Resource links provided by NLM:


Further study details as provided by Rehabilitation Institute of Chicago:

Primary Outcome Measures:
  • Berg Balance Scale [ Time Frame: 8 weeks ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Dynamic Gait Index [ Time Frame: 8 weeks ] [ Designated as safety issue: Yes ]
  • Parkinson's Disease QOL Questionnaire (PDQ-8) [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
  • Postural Sway [ Time Frame: 8 weeks ] [ Designated as safety issue: Yes ]

Enrollment: 10
Study Start Date: August 2010
Study Completion Date: February 2011
Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Balance Training
Balance training using Wii Fit Balance Board
Other: Balance Training
Group balance training sessions three times a week for 8 weeks
Other Name: Wii (Registered Trademark) Balance Board

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Adult, 18 years or greater
  2. The patient is able to provide informed consent.
  3. Definitive Idiopathic Parkinson's Disease as diagnosed by a Neurologist
  4. Hoehn and Yahr Stage 2.5-3
  5. Able to ambulate at least 150 ft without an assistive device per patient report
  6. On stable doses of Parkinson's medications for at least 2 weeks prior to study onset
  7. Endurance sufficient to stand at least 20 minutes unassisted per patient report

Exclusion Criteria:

  1. Mini Mental Status Exam (MMSE) < 24
  2. Anticipated change in Parkinson's medications in the duration of study
  3. Uncontrolled orthostasis
  4. Symptomatic coronary artery disease
  5. Fracture of lower limb within 6 months prior to study onset
  6. Other neurologic diagnosis, including Multiple Sclerosis
  7. Other vestibular disease
  8. Untreated severe depression (depression of greater than or equal 20 on the Geriatric Depression Scale)
  9. Acute illness
  10. History of, or current, alcohol abuse
  11. Significant visual impairment that would inhibit ability to participate in study, with distance vision >20/40
  12. Drug induced or inherited Parkinson's Disease
  13. Physical therapy within the month prior to study entry
  14. Use of the Wii balance board at home as an exercise program
  15. Significant camptocormia
  16. Physical Therapy during the study duration
  17. Any medical condition which the physician investigator determines would compromise the safety of exercise program for the subject.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01228851

Locations
United States, Illinois
Rehabilitation Institute of Chicago
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Rehabilitation Institute of Chicago
  More Information

No publications provided

Responsible Party: Santiago Toledo MD, Rehabilitation Institute of Chicago
ClinicalTrials.gov Identifier: NCT01228851     History of Changes
Other Study ID Numbers: 30775
Study First Received: August 31, 2010
Last Updated: July 26, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Rehabilitation Institute of Chicago:
Parkinson's Disease
Rehabilitation
Balance
Exercise
Parkinson's disease with balance deficits
H&Y 2.5-3

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on September 18, 2014